InvestorsHub Logo
Followers 1
Posts 159
Boards Moderated 0
Alias Born 05/21/2019

Re: None

Tuesday, 03/01/2022 1:14:57 PM

Tuesday, March 01, 2022 1:14:57 PM

Post# of 1102
Clinical Trial Results!

RECOVERY AND SURVIVAL IN COVID-19 RESPIRATORY FAILURE, WHEN TREATED WITH AVIPTADIL

Aviptadil helps to resolve respiratory failure and
extend survival at tertiary care sites in COVID-19

https://www.nrxpharma.com/wp-content/uploads/2022/03/ZYESAMI-Clinical-Trial-Results.pdf

https://www.nrxpharma.com/ceo-update-zyesami-clinical-trial-results-covid-aiv-presented-at-peer-reviewed-congress-on-retroviruses-and-opportunistic-infections/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NRXP News